Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-3718 in PPI-refractory GERD
NCT02637557Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IW-3718 in gastroesophageal reflux disease (GERD), sponsored by Ironwood Pharmaceuticals. Started Mar 2016; status: completed.
02
Drugs
IW-3718
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02637557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637557.